Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Hepatic Disorders and Covid-19: From Pathophysiology to Treatment Strategy Publisher Pubmed



Shiri Aghbash P1, 2 ; Ebrahimzadeh Leylabadlo H3 ; Fathi H2, 4 ; Bahmani M2, 5 ; Chegini R6 ; Bannazadeh Baghi H1, 2, 7
Authors

Source: Canadian Journal of Gastroenterology and Hepatology Published:2022


Abstract

Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs such as the lungs, kidneys, liver, heart, and brain have been identified as priority organs. Liver diseases are considered a risk factor for high mortality from the COVID-19 pandemic. Besides, liver damage has been demonstrated in a substantial proportion of patients with COVID-19, especially those with severe clinical symptoms. Furthermore, antiviral medications, immunosuppressive drugs after liver transplantation, pre-existing hepatic diseases, and chronic liver diseases such as cirrhosis have also been implicated in SARS-CoV-2-induced liver injury. As a result, some precautions have been taken to prevent, monitor the virus, and avoid immunocompromised and susceptible individuals, such as liver and kidney transplant recipients, from being infected with SARS-CoV-2, thereby avoiding an increase in mortality. The purpose of this review was to examine the impairment caused by SARS-CoV-2 infection and the impact of drugs used during the pandemic on the mortality range and therefore the possibility of preventive measures in patients with liver disease. © 2022 Parisa Shiri Aghbash et al.
2. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
3. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
Experts (# of related papers)
Other Related Docs
4. An Overview on Acute Kidney Injury Following Covid-19, Journal of Parathyroid Disease (2023)
16. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
17. Covid-19 and the Kidney; Mechanisms of Tubular Injury by Sars-Cov-2, Journal of Renal Injury Prevention (2021)
18. Clinical Characteristics of Covid-19-Infected Cancer Patients, Isfahan, Iran, Journal of Research in Medical Sciences (2022)
19. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)